Monthly Archives: October 2013

How Much Is Your Patent Worth

October 30, 2013 | Comments are closed

In collaboration with a senior patent licensing expert, BioIsrael is offering a new service that enables companies and individuals to establish the worth of a patent that they are holding in today’s market: The new service analyzes the following value indicators: Backward citations, forward citations, the number of claims, the...

MD Biosciences and other CROs at Biotech China

October 27, 2013 | Comments are closed

MD Biosciences is a pre-clinical contract research organization (CRO) providing in vitro and in vivo nonclinical efficacy studies as well as a clinical biomarker and general chemistry analysis. The company’s focus is on inflammation, neurological and cardiovascular conditions. MD BioSciences’ approach is to understand the need in the clinic and...

Xonovo Drug for Alzheimer’s

October 20, 2013 | Comments are closed

Xonovo Inc. and the Oklahoma Medical Research Foundation (OMRF) announced that they entered into an Exclusive Worldwide Licensing Agreement for intellectual property rights related to small molecule synthetic derivatives of the natural brain metabolite Lanthionine Ketimine (LK), developed at OMRF. The lead molecule – XN-001 – has shown promising results...